FDA NDC Directory · JSON-LD · Markdown

Terlivaz

NDC 43825-200 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameTerlipressin
Labeler / ManufacturerMallinckrodt Hospital Products Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022231
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTERLIPRESSIN (.85 mg/5mL)
Marketing started20220914
Package count1

External sources

Source: openFDA. Public-domain (CC0).